Shrooms could soon be legal in more places, and billions of dollars are in play. VICE News reports on whether psilocybin is doomed to become a therapy by and for the elite.
View Vice News Tonight / S6 EP1
A library of psychedelic knowledge, from clinical studies to turn of the century catalogs, may make psychedelic patents more fair.
Read Freethink* Article
The non-profit Freedom to Operate used research from chemists and crystallographers to argue in a legal filing that Compass’ form of synthetic psilocybin is not a new invention.
Read Tech By VICE Article
In August, Fitchburg-based Usona Institute started construction on a campus that it hopes will become a global center for research on psilocybin and other consciousness-expanding medicines.
Read Wisconsin Health News Article
There was a time when LSD and other vision-inducing psychedelic drugs were associated with the American counter-culture and for conservative observers with license and dissent …
Read Points History Article
Psychedelics have shown great promise in treating mental-health conditions, but their use is severely limited by legal obstacles, which could be overcome.
Read Nature Medicine Article
There has been a surge in patents of psychedelic therapies. Some recent headlines have suggested that patent claims on psychedelics represent a sign that “capitalism has gone rogue.” Others suggest that investors are debating ownership of a psychedelic future.
Read Psychology Today Article
Companies can own potentially valuable psychedelic IP without anyone even knowing if it works.
Read VICE Article
A recent application from CB Therapeutics on biosynthetic psilocybin is emblematic of the IP concerns around novelty and obviousness the psychedelic field will face.
Read VICE Article